HUBEI MINKANG PHARMACEUTICAL LTD.
CIK 0001375850
Revenue (TTM)
$10.89M
+5.9% YoY
Q3 Nov 2014
Net Income (TTM)
−$320.65K
−86.8% YoY
Q3 Nov 2014
EPS Diluted (TTM)
—
Q3 Nov 2014
Gross Margin
44.8%
Q3 Nov 2014
Operating Margin
-1.5%
Q3 Nov 2014
Net Margin
-2.9%
Q3 Nov 2014
Free Cash Flow (TTM)
−$2.07M
Q3 Nov 2014
Cash
$6.23M
Q3 Nov 2014
Total Debt
—
Q3 Nov 2014
Shares Outstanding
52.19M sh
Q3 Nov 2014